Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neurol Sci ; 22(1): 101-3, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11487180

RESUMO

Progressive supranuclear palsy (PSP) is a rare form of parkinsonism. The incidence rates are about 0.3-1.1 cases per 100,000 persons. The only two case-control studies performed up to now show conflictual results as regards education and residence in rural areas. Recently, a cluster of PSP and atypical parkinsonism has been observed in French Antilles. The hypothesis is that a consumption of both tropical fruit and herbal tea may be associated with PSP onset. Some PSP families with a probably autosomal dominant transmission have been described. A high frequency of a tau haplotype (H1/H1) associated with PSP is reported by some authors. The significance of this association is still not clear. We have performed a case-control study on 58 PSP cases, 116 hospital controls and 58 population controls.


Assuntos
Paralisia Supranuclear Progressiva/epidemiologia , Idade de Início , Bebidas/efeitos adversos , Exposição Ambiental , Feminino , Testes Genéticos , Guadalupe/epidemiologia , Humanos , Incidência , Masculino , Mutação/genética , Doenças Profissionais/epidemiologia , Prevalência , Fatores de Risco , Fatores Sexuais , Paralisia Supranuclear Progressiva/fisiopatologia , Proteínas tau/genética
2.
Mov Disord ; 12(4): 506-8, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9251067

RESUMO

Sleep benefit (SB) In Parkinson's disease (PD) is not well characterized. To determine SB frequency, as well as to characterize and correlate it with other disease variables, we evaluated prospectively a consecutive series of 312 PD patients by means of a structured questionnaire: 55% reported having SB and 35% reported that awakening was their best time of the day. Because of SB, 21% of the entire population were able to skip or delay medication. The mean duration of the phenomenon was 85.4 +/- 67 min. Patients with SB were significantly older (p < 0.0002), had disease longer (p < 0.05), and were often men (chi 2 = 3.5, df 1, p = 0.05). Patients with SB took sleep medication with similar frequency as those without SB. There were no differences in hours of sleep or sleep latency. Sleep problems such as nightmares or somnambulism, but not the number of sleep awakenings, were similar in both groups. In conclusion, SB is a frequent phenomenon, especially in men, elderly patients, and patients with longer disease duration. SB enables the morning L-dopa dose to be postponed in approximately 50% of patients.


Assuntos
Antiparkinsonianos/farmacologia , Ritmo Circadiano/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Doença de Parkinson/fisiopatologia , Sono/efeitos dos fármacos , Idoso , Feminino , Humanos , Levodopa/farmacologia , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/tratamento farmacológico , Estudos Prospectivos , Inquéritos e Questionários , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA